High prevalence of NTRK fusions in sporadic dMMR/MSI mCRC RAS/RAF wild-type: an opportunity for a post-immune checkpoint inhibitors progression rescue strategy
Author:
M. Svrcek,A. Cayre,T. Samaille,R. Colle,L. Mas,P. Bourgoin,E. Guillerm,R. Cohen,F. Penault-Llorca,T. André,N. Radosevic-Robin
Publication:
ESMO Gastrointestinal Oncology
© 2024 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.